HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The nemaline myopathy-causing E117K mutation in β-tropomyosin reduces thin filament activation.

Abstract
The effect of the nemaline myopathy-causing E117K mutation in β-tropomyosin (TM) on the structure and function of this regulatory protein was studied. The E117K mutant was found to have indistinguishable actin affinity compared with wild-type (WT) and similar secondary structure as measured by circular dichroism. However the E117K mutation significantly lowered maximum activation of actomyosin ATPase. To explain the molecular mechanism of impaired ATPase activation, WT and E117K TMs were covalently labeled at Cys-36 with 5-iodoacetimido-fluorescein and incorporated into ghost muscle fibers. The changes in the position and flexibility of tropomyosin strands on the thin filaments were observed at simulation of weak and strong binding states of actomyosin at high or low Ca(2+) by polarized fluorescence techniques. The E117K mutation was found to shift the tropomyosin strands towards the closed position and restrict the tropomyosin displacement during the transformation of actomyosin from weak to strong binding state thus leading to a reduction in thin filament activation.
AuthorsOlga E Karpicheva, Paul Robinson, Adam Piers, Yurii S Borovikov, Charles S Redwood
JournalArchives of biochemistry and biophysics (Arch Biochem Biophys) Vol. 536 Issue 1 Pg. 25-30 (Aug 01 2013) ISSN: 1096-0384 [Electronic] United States
PMID23689010 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Actins
  • Tropomyosin
  • Myosins
Topics
  • Actin Cytoskeleton (metabolism)
  • Actins (metabolism)
  • Circular Dichroism
  • Enzyme Activation
  • Fluorescence Polarization
  • Humans
  • Myopathies, Nemaline (genetics, metabolism)
  • Myosins (metabolism)
  • Point Mutation
  • Protein Conformation
  • Protein Folding
  • Tropomyosin (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: